Trial ID or NCT#

NCT02553824

Status

not recruiting iconNOT RECRUITING

Purpose

This study will demonstrate the efficacy of Qsymia versus placebo in treating bulimia nervosa and binge eating disorder.

Official Title

Qsymia (Phentermine-topiramate) to Reduce Binge Eating/Purging in Patients With Bulimia Nervosa and Binge Eating Disorder

Eligibility Criteria

Ages Eligible for Study: 18 Years to 60 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Debra Safer
Debra Safer
Psychiatrist
Associate Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)) at the Stanford University Medical Center
Sarah Adler
Sarah Adler
Psychologist
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Shebani Sethi Dalai MD
Clinical Instructor, Psychiatry and Behavioral Sciences

Contact us to find out if this trial is right for you.

CONTACT

Debra L Safer, MD
(650) 723-7928